Acute and chronic systemic administration of morphine is known to suppress immune function; however, the effect of chronic intrathecal (IT) morphine on immune function in inflammatory-induced pain is still unclear. This study examined the effects on the immune system of IT morphine in rats with formalin-induced pain. Lumbar IT catheters were implanted in rats and saline or 2.5, 5.0 or 10.0 μg/h morphine were administered for 7 days. On the last day, formalin-induced inflammatory pain was induced in rat hind paws and pain intensity was assessed. Rat spleens were then harvested for immune function assay. The IT morphine induced a dose-dependent analgesic effect and lactic acid dehydrogenase release assay showed dose-dependent suppression of natural killer cell activity. Concanavalin-A-induced splenocyte proliferation assay showed IT morphine to suppress T lymphocyte function in a dose-dependent manner. Flow cytometry showed IT morphine significantly to decrease T lymphocyte function and the percentages of T lymphocyte subsets in a dose-dependent manner. Hence, in inflammatory-induced pain IT morphine was found to suppress immune function. Chronic IT morphine should be used cautiously to treat chronic pain in immunocompromised cases.
HarrisPDGarretR: Susceptibility of addicts to infection and neoplasia. N Engl J Med1972;287: 310.
2.
BeckettHD: Systemic infections in heroin addicts. Lancet1968; i: 48.
3.
SacerdoteP: Opioids and the immune system. Palliat Med2006; 20 (suppl 1): s9–s15.
4.
YeagerMPColacchioTAYuCT: Morphine inhibits spontaneous and cytokine-enhanced natural killer cell cytotoxicity in volunteers. Anesthesiology1995; 83: 500–508.
5.
AlonzoNCBayerBM: Opioids, immunology, and host defences of intravenous drug abusers. Infect Dis Clin North Am2002; 16: 553–569.
6.
EisensteinTKHilburgerME: Opioid modulation of immune responses: Effects on phagocyte and lymphoid cell populations. J Neuroimmunol1998; 83: 36–44.
7.
SaurerTBCarriganKAIjamesSG: Morphine-induced alterations of immune status are blocked by the dopamine D2-like receptor agonist 7-OH-DPAT. J Neuroimmunol2004; 148: 54–62.
8.
WangJCharboneauRBalasubramanianS: Morphine modulates lymph node-derived T lymphocyte function: Role of caspase-3, −8, and nitric oxide. J Leukoc Biol2001; 70: 527–536.
9.
RathmellJPPinoCATaylorR: Intrathecal morphine for postoperative analgesia: A randomized, controlled, dose-ranging study after hip and knee arthroplasty. Anesth Analg2003; 97: 1452–1457.
10.
Gilmer-HillHSBogganJESmithKA: Intrathecal morphine delivered via subcutaneous pump for intractable pain in pancreatic cancer. Surg Neurol1999; 51: 6–11.
11.
MarchandFPerrettiMMcMahonSB: Role of the immune system in chronic pain. Nat Rev Neurosci2005; 6: 521–532.
12.
ZimmermannM: Ethical guidelines for investigations of experimental pain in conscious animals. Pain1983; 16: 109–110.
13.
YakshTLRudyTA: Chronic catheterization of the spinal subarachnoid space. Physiol Behav1976; 17: 1031–1036.
14.
DubuissonDDennisSG: The formalin test: A quantitative study of the analgesic effects of morphine, meperidine, and brain stem stimulation in rats and cats. Pain1977; 4: 161–174.
15.
PalmSMignatCKuhnK: Phytohemagglutinin-dependent T-cell proliferation is not impaired by morphine. Methods Find Exp Clin Pharmacol1996; 18: 159–165.
16.
KorzeniewskiCCallewaertDM: An enzyme-release assay for natural cytotoxicity. J Immunol Methods1983; 64: 313–320.
17.
NiemiLPitkanenMTTuominenMK: Comparison of intrathecal fentanyl infusion with intrathecal morphine infusion or bolus for postoperative pain relief after hip arthroplasty. Anesth Analg1993; 77: 126–130.
18.
BeyreutherBKCallizotNBrotMD: Antinociceptive efficacy of lacosamide in rat models for tumor- and chemotherapy-induced cancer pain. Eur J Pharmacol2007; 565: 98–104.
19.
WhitesideTLHerbermanRB: The role of natural killer cells in human disease. Clin Immunol Immunopathol1989; 53: 1–23.
20.
Van ThielDHChenKNChienMC: T-lymphocyte subsets in gut and blood of liver transplant recipients with and without cytomegalovirus gastroenteritis. Dig Dis Sci1989; 34: 1751–1757.
21.
BayerBMDaussinSHernandezM: Morphine inhibition of lymphocyte activity is mediated by an opioid dependent mechanism. Neuropharmacology1990; 29: 369–374.
22.
TsaiYCWonSJLinMT: Effects of morphine on immune response in rats with sciatic constriction injury. Pain2000; 88: 155–160.
23.
YokotaTUeharaKNomotoY: Intrathecal morphine suppresses NK cell activity following abdominal surgery. Can J Anaesth2000; 47: 303–308.
24.
AlexanderMDanielTChaudryIH: Opiate analgesics contribute to the development of post-injury immunosuppression. J Surg Res2005; 129: 161–168.
25.
AroraPKFrideEPetittoJ: Morphine-induced immune alterations in vivo. Cell Immunol1990; 126: 343–353.
26.
FreierDOFuchsBA: Morphine-induced alterations in thymocyte subpopulations of B6C3F1 mice. J Pharmacol Exp Ther1993; 265: 81–88.
27.
HamraJGYakshTL: Equianalgesic doses of subcutaneous but not intrathecal morphine alter phenotypic expression of cell surface markers and mitogen-induced proliferation in rat lymphocytes. Anesthesiology1996; 85: 355–365.
28.
ShavitYTermanGWLewisJW: Effects of footshock stress and morphine on natural killer lymphocytes in rats: Studies of tolerance and cross-tolerance. Brain Res1986; 372: 382–385.
FechoKMaslonekKADykstraLA: Assessment of the involvement of central nervous system and peripheral opioid receptors in the immunomodulatory effects of acute morphine treatment in rats. J Pharmacol Exp Ther1996; 276: 626–636.
31.
FechoKMaslonekKADykstraLA: Alterations of immune status induced by the sympathetic nervous system: Immunomodulatory effects of DMPP alone and in combination with morphine. Brain Behav Immun1993; 7: 253–270.
32.
FreierDOFuchsBA: A mechanism of action for morphine-induced immunosuppression: Corticosterone mediates morphine-induced suppression of natural killer cell activity. J Pharmacol Exp Ther1994; 270: 1127–1133.
33.
FloresLRHernandezMCBayerBM: Acute immunosuppressive effects of morphine: Lack of involvement of pituitary and adrenal factors. J Pharmacol Exp Ther1994; 268: 1129–1134.
